Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• (untitled)2 passages
• A biomarker study in Peruvian males with breast cancer.1 passage
• Abdominal metastases of primary extremity soft tissue sarcoma: A systematic review.1 passage
• Accelerated partial breast irradiation: Past, present, and future.1 passage
• Active surveillance in low risk papillary thyroid carcinoma.1 passage
• Adaptation of international coronavirus disease 2019 and breast cancer guidelines to local context.1 passage
• Adjuvant chemotherapy for rectal cancer: Is it needed?1 passage
• Adjuvant therapy for lung neuroendocrine neoplasms.1 passage
• Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approaches.1 passage
• Albumin-bound paclitaxel as new treatment for metastatic cholangiocarcinoma: A case report.1 passage
• Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia: A case report.1 passage
• Are all prostate cancer patients "fit" for salvage radiotherapy?1 passage
• Artificial intelligence in dentistry: Harnessing big data to predict oral cancer survival.1 passage
• Assessment of breast cancer immunohistochemistry and tumor characteristics in Nigeria.1 passage
• Assessment of burden and coping strategies among caregivers of cancer patients in sub-Saharan Africa.1 passage
• Association of colorectal cancer with pathogenic Escherichia coli: Focus on mechanisms using optical imaging.1 passage
• Autosegmentation of cardiac substructures in respiratory-gated, non-contrasted computed tomography images.1 passage
• Awareness that early cancer lump is painless could decrease breast cancer mortality in developing countries.1 passage
• Axillary lymph node management in breast cancer with positive sentinel lymph node biopsy.1 passage
• B-cell lymphoma-2 inhibition and resistance in acute myeloid leukemia.1 passage
• BRCA mutations and gastrointestinal cancers: When to expect the unexpected?1 passage
• Bethesda System for Reporting Thyroid Cytopathology: A three-year study at a tertiary care referral center in Saudi Arabia.1 passage
• Bilateral diffuse grade 5 radiation pneumonitis after intensity modulated radiation therapy for localized lung cancer.1 passage
• Biological mesh reconstruction of the pelvic floor following abdominoperineal excision for cancer: A review.1 passage
• Biomarkers in triple negative breast cancer: A review.1 passage
• Body mass index trends and quality of life from breast cancer diagnosis through seven years' survivorship.1 passage
• Bone and soft tissue tumors presenting as sciatic notch dumbbell masses: A critical differential diagnosis of sciatica.1 passage
• Breast cancer: Muscarinic receptors as new targets for tumor therapy.1 passage
• Breast metastasis from primary lung adenocarcinoma in a young woman: A case report and literature review.1 passage
• Breathing adapted radiation therapy for leukemia relapse in the breast: A case report.1 passage
• CITED2 and the modulation of the hypoxic response in cancer.1 passage
• COVID-19 and information and communication technology in radiation oncology: A new paradigm.1 passage
• COVID-19: Where is the treatment?1 passage
• Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?1 passage
• Cancer prevention in patients with human immunodeficiency virus infection.1 passage
• Cancer screening: Between appropriateness and effectiveness.1 passage
• Carcinoma of unknown primary and paraneoplastic dermatomyositis.1 passage
• Cardiovascular risk management in cancer survivors: Are we doing it right?1 passage
• Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?1 passage
• Cellular based treatment modalities for unresectable hepatocellular carcinoma.1 passage
• Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices.1 passage
• Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide.1 passage
• Characteristics of1 passage
• Charcot-Marie-Tooth hereditary neuropathy revealed after administration of docetaxel in advanced breast cancer.1 passage
• Chemotherapy rechallenge in metastatic colon cancer: A case report and literature review.1 passage
• Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention.1 passage
• Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review.1 passage
• Cigarette smoking, dietary habits and genetic polymorphisms in1 passage
• Circular RNA and its potential as prostate cancer biomarkers.1 passage
• Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer.1 passage
• Circulating tumor DNA: Where are we now? A mini review of the literature.1 passage
• Clear cell sarcoma in unusual sites mimicking metastatic melanoma.1 passage
• Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer.1 passage
• Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.1 passage
• Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients.1 passage
• Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy.1 passage
• Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention.1 passage
• Colorectal liver metastases: Current management and future perspectives.1 passage
• Combination drug regimens for metastatic clear cell renal cell carcinoma.1 passage
• Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model.1 passage
• Combination therapies improve the anticancer activities of retinoids in neuroblastoma.1 passage
• Comparative analysis of the effectiveness of abiraterone before and after docetaxel in patients with metastatic castration-resistant prostate cancer.1 passage
• Comparison of efficacy between adjuvant chemotherapy and chemoradiation therapy for pancreatic cancer: AJCC stage-based approach.1 passage
• Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data.1 passage
• Complete response in anaplastic lymphoma kinase-rearranged oncocytic thyroid cancer: A case report and review of literature.1 passage
• Concurrent chemoradiation for high-risk prostate cancer.1 passage
• Concurrent renal cell carcinoma and hematologic malignancies: Nine case reports.1 passage
• Contralateral prophylactic mastectomy rate stable at major Canadian breast cancer center.1 passage
• Correlation between breast cancer and lifestyle within the Gulf Cooperation Council countries: A systematic review.1 passage
• Critically ill patients with cancer: A clinical perspective.1 passage
• Current and future treatment of anaplastic lymphoma kinase-rearranged cancer.1 passage
• Current challenges in applying gene-driven therapies in clinical lung cancer practice.1 passage
• Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review.1 passage
• Current role of spacers for prostate cancer radiotherapy.1 passage
• Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer.1 passage
• Current status of ultrasound-guided surgery in the treatment of breast cancer.1 passage
• Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians.1 passage
• Current treatment options for patients with initially unresectable isolated colorectal liver metastases.1 passage
• Current update on imaging for pancreatic neuroendocrine neoplasms.1 passage
• Cytotoxic CD8+ T cells and tissue resident memory cells in colorectal cancer based on microsatellite instability and BRAF status.1 passage
• DNA extraction from paraffin embedded colorectal carcinoma samples: A comparison study of manual1 passage
• Deep diving in the PACIFIC: Practical issues in stage III non-small cell lung cancer to avoid shipwreck.1 passage
• Dentinogenic ghost cell tumor: A case report.1 passage
• Diacerein treatment prevents colitis-associated cancer in mice.1 passage
• Difficult endoscopic diagnosis of a pancreatic plasmacytoma: Case report and review of literature.1 passage
• Direct therapeutic intervention for advanced pancreatic cancer.1 passage
• Distance caregiving a family member with cancer: A review of the literature on distance caregiving and recommendations for future research.1 passage
• Does low volume high-intensity interval training elicit superior benefits to continuous low to moderate-intensity training in cancer survivors?1 passage
• Effectiveness of a novel, fixed dose combination of netupitant and palonosetron in prevention of chemotherapy induced nausea and vomiting: A real-life study from India.1 passage
• Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer.1 passage
• Efficacy, patterns of use and cost of Pertuzumab in the treatment of HER2+ metastatic breast cancer in Singapore: The National Cancer Centre Singapore experience.1 passage
• Embracing cancer immunotherapy with vital micronutrients.1 passage
• Endometrial cancer among a cohort of urban Haitian immigrants.1 passage
• Endometrial clear cell carcinoma invading the right oviduct with a cooccurring ipsilateral oviduct adenomatoid tumor: A case report.1 passage
• Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma.1 passage
• Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?1 passage
• Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma.1 passage
• Evolutionary model of brain tumor circulating cells: Cellular galaxy.1 passage
• Evolving role of Sorafenib in the management of hepatocellular carcinoma.1 passage
• Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy.1 passage
• Extrapulmonary small cell carcinoma of lymph node: Pooled analysis of all reported cases.1 passage
• FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer.1 passage
• Factors associated with cervical cancer screening in a safety net population.1 passage
• Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp.1 passage
• Features of primary pancreatic lymphoma: A bi-institutional review with an emphasis on typical and atypical imaging features.1 passage
• Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas.1 passage
• First report of small cell lung cancer with PTHrP-induced hypercalcemic pancreatitis causing disconnected duct syndrome.1 passage
• Fluoropyrimidine-induced cardiotoxicity.1 passage
• Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients.1 passage
• From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis.1 passage
• Functional Gait Assessment scale in the rehabilitation of patients after vestibular tumor surgery in an acute hospital.1 passage
• Further the liquid biopsy: Gathering pieces of the puzzle of genometastasis theory.1 passage
• GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma.1 passage
• GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic.1 passage
• GOECP/SEOR radiotherapy guidelines for small-cell lung cancer.1 passage
• GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours.1 passage
• Gallbladder adenocarcinoma and paraneoplastic parathyroid hormone mediated hypercalcemia.1 passage
• Gangliocytic paraganglioma: An overview and future perspective.1 passage
• Gastric and duodenal polyps in familial adenomatous polyposis patients: Conventional endoscopy1 passage
• Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.1 passage
• Gastric myeloid sarcoma: A case report.1 passage
• Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach?1 passage
• Germline mutations in Thai patients with nonmucinous epithelial ovarian cancer.1 passage
• Giant exophytic renal angiomyolipoma masquerading as a retroperitoneal liposarcoma: A case report and review of literature.1 passage
• Glycoconjugation: An approach to cancer therapeutics.1 passage
• Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes.1 passage
• Healthcare delivery interventions to reduce cancer disparities worldwide.1 passage
• Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.1 passage
• Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy: A focus on relapsed/refractory germ cell tumors.1 passage
• Hepatic Langerhans cell histiocytosis: A review.1 passage
• Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report.1 passage
• Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer.1 passage
• Hong Kong female's breast cancer awareness measure: Cross-sectional survey.1 passage
• Horn of plenty: Value of the international registry for pediatric chronic myeloid leukemia.1 passage
• How best to manage gastrointestinal stromal tumor.1 passage
• Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: The Singapore experience.1 passage
• Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives.1 passage
• Imaging diagnosis of bronchogenic carcinoma (the forgotten disease) during times of COVID-19 pandemic: Current and future perspectives.1 passage
• Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study.1 passage
• Immune response evaluation criteria in solid tumors for assessment of atypical responses after immunotherapy.1 passage
• Immunotherapies in sarcoma: Updates and future perspectives.1 passage
• Immunotherapy - new perspective in lung cancer.1 passage
• Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations.1 passage
• Impact of conditioning regimen on peripheral blood hematopoietic cell transplant.1 passage
• Impact of primary tumour location on colorectal liver metastases: A systematic review.1 passage
• Inorganic phosphate in the development and treatment of cancer: A Janus Bifrons?1 passage
• Integrating palliative care in oncologic emergency departments: Challenges and opportunities.1 passage
• Intensive care outcomes in adult hematopoietic stem cell transplantation patients.1 passage
• Interconversion of two commonly used performance tools: An analysis of 5844 paired assessments in 1501 lung cancer patients.1 passage
• Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma.1 passage
• Intestinal metastasis from breast cancer: Presentation, treatment and survival from a systematic literature review.1 passage
• Intimal sarcoma of the pulmonary artery with multiple lung metastases: Long-term survival case.1 passage
• Intravascular large B-cell lymphoma presenting with altered mental status: A case report.1 passage
• Intravascular lymphoma with hypopituitarism: A case report.1 passage
• Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: Concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence.1 passage
• Is breast conservative surgery a reasonable option in multifocal or multicentric tumors?1 passage
• Is there a place for optimizing thoracic radiotherapy in limited-stage small cell lung cancer after twenty years?1 passage
• Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer?1 passage
• Is there a role for treatment-oriented surgery in liver metastases from gastric cancer?1 passage
• Is there still a place for docetaxel rechallenge in prostate cancer?1 passage
• Isolated limb infusion chemotherapy with or without hemofiltration for recurrent limb melanoma.1 passage
• Isolated subcutaneous implantation of a borderline ovarian tumor: A case report and review of the literature.1 passage
• Jejunostomy in the palliative treatment of gastric cancer: A clinical prognostic score.1 passage
• Latent brain infection with1 passage
• Lay perceptions of breast cancer in Western Kenya.1 passage
• Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.1 passage
• Leptin signaling and cancer chemoresistance: Perspectives.1 passage
• Leptin-induced Notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance.1 passage
• Levels of neutrophil gelatinase-assosciated lipocalin in patients with head and neck squamous cell carcinoma in Indian population from Haryana state.1 passage
• Lingual lymph nodes: Anatomy, clinical considerations, and oncological significance.1 passage
• Liposarcoma of the breast arising in a malignant phyllodes tumor: A case report and review of the literature.1 passage
• Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes.1 passage
• Liver transplantation in malignant disease.1 passage
• Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsy.1 passage
• Long-term complete response in metastatic poorly-differentiated neuroendocrine rectal carcinoma with a multimodal approach: A case report.1 passage
• Long-term outcomes of interventions for radiation-induced xerostomia: A review.1 passage
• Long-term results of the treatment of Hodgkin's lymphoma in a resource-constrained setting: Real-world data from a single center.1 passage
• Long-term stabilization of metastatic melanoma with sodium dichloroacetate.1 passage
• Lymphocyte subsets predictive value and possible involvement of human papilloma virus infection on breast cancer molecular subtypes.1 passage
• MUTYH: Not just polyposis.1 passage
• Macrometastasis at selective lymph node biopsy: A practical going-for-the-one clinical scoring system to personalize decision making.1 passage
• Magnetic resonance imaging for diagnosis and neoadjuvant treatment evaluation in locally advanced rectal cancer: A pictorial review.1 passage
• Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know.1 passage
• Male papillary breast cancer treated by wide resection and latissimus dorsi flap reconstruction: A case report and review of the literature.1 passage
• Malignant hepatic vascular tumors in adults: Characteristics, diagnostic difficulties and current management.1 passage
• Malignant peripheral nerve sheath tumor of proximal third tibia.1 passage
• Management of neuroblastoma in limited-resource settings.1 passage
• Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions.1 passage
• Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report.1 passage
• Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors.1 passage
• Metastatic clear cell renal cell carcinoma in isolated retroperitoneal lymph node without evidence of primary tumor in kidneys: A case report.1 passage
• Metastatic disease to the liver: Locoregional therapy strategies and outcomes.1 passage
• Metastatic hormone-sensitive prostate cancer: How should it be treated?1 passage
• Metastatic potential and prognostic significance of SOX2: A meta-analysis.1 passage
• Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key.1 passage
• Microenvironment and endocrine resistance in breast cancer: Friend or foe?1 passage
• Mismatch repair protein expression and intratumoral budding in rectal cancer are associated with an increased pathological complete response to preoperative chemoradiotherapy: A case-control study.1 passage
• Modulators of alternative splicing as novel therapeutics in cancer.1 passage
• Multidisciplinary approach of colorectal cancer liver metastases.1 passage
• Multidisciplinary treatment of soft tissue sarcomas: An update.1 passage
• Mutational analysis of1 passage
• Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer.1 passage
• Narrowing the focus: Therapeutic cell surface targets for refractory triple-negative breast cancer.1 passage
• National Comprehensive Cancer Network guidelines compliance of a sarcoma service: A retrospective review.1 passage
• Neoadjuvant chemotherapy followed by surgery in gastric cancer patients with extensive lymph node metastasis.1 passage
• Neoadjuvant therapy for gastroesophageal adenocarcinoma.1 passage
• Neoadjuvant treatment for resectable pancreatic adenocarcinoma.1 passage
• Nephrotoxicity in cancer treatment: An overview.1 passage
• Neuroendocrine tumors resistant to mammalian target of rapamycin inhibitors: A difficult conversion from biology to the clinic.1 passage
• New findings on thymic epithelial tumors: Something is changing.1 passage
• New frontiers in focal therapy for prostate cancer: Prostate-specific membrane antigen positron emission tomography/magnetic resonance imaging.1 passage
• New insights into tumor dormancy: Targeting DNA repair pathways.1 passage
• New standard in locally advanced rectal cancer.1 passage
• Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease.1 passage
• Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma.1 passage
• Novel molecular panel for evaluating systemic inflammation and survival in therapy naïve glioma patients.1 passage
• Novel molecular targets in hepatocellular carcinoma.1 passage
• Objective response rate assessment in oncology: Current situation and future expectations.1 passage
• Oligometastases in prostate cancer: Ablative treatment.1 passage
• Oligometastatic disease, the curative challenge in radiation oncology.1 passage
• Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer.1 passage
• Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy.1 passage
• Overall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands: Analysis of 2210 patients.1 passage
• Overview of recent advances in metastatic triple negative breast cancer.1 passage
• Overview, prevention and management of chemotherapy extravasation.1 passage
• PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report.1 passage
• Palliative surgery for Krukenberg tumors - 12-year experience and review of the literature.1 passage
• Pancreatic adenocarcinoma with early esophageal metastasis: A case report and review of literature.1 passage
• Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils?1 passage
• Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms.1 passage
• Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series.1 passage
• Pelvic radiation disease: Updates on treatment options.1 passage
• Personalized chemotherapy in clear cell adenocarcinoma of the urethra: A case report.1 passage
• Phytochemically rich dietary components and the risk of colorectal cancer: A systematic review and meta-analysis of observational studies.1 passage
• Pituitary carcinoma: Two case reports and review of literature.1 passage
• Plasma cell leukemia - one in a million: A case report.1 passage
• Platinum-induced neurotoxicity: A review of possible mechanisms.1 passage
• Portal vein embolization effect on colorectal cancer liver metastasis progression: Lessons learned.1 passage
• Positron emission tomography complete metabolic response as a favorable prognostic predictor in esophageal cancer following neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil.1 passage
• Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story.1 passage
• Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma.1 passage
• Powerful quantifiers for cancer transcriptomics.1 passage
• Practice change in the management of metastatic urothelial carcinoma after ASCO 2020.1 passage
• Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia.1 passage
• Predictors of distant metastasis in acinic cell carcinoma of the parotid gland.1 passage
• Preoperative markers for the prediction of high-risk features in endometrial cancer.1 passage
• Preoperative rectal tumor embolization as an adjunctive tool for bloodless abdominoperineal excision: A case report.1 passage
• Present laparoscopic surgery for colorectal cancer in Japan.1 passage
• Primary small cell oesophageal carcinoma: A retrospective study of different ‎treatment modalities.1 passage
• Prognostic importance of lymph node yield after curative resection of gastroenteropancreatic neuroendocrine tumours.1 passage
• Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: A retrospective study.1 passage
• Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer.1 passage
• Progress in immunotherapy for small cell lung cancer.1 passage
• Prophylactic lateral pelvic lymph node dissection in stage IV low rectal cancer.1 passage
• Prostatic adenocarcinoma oncocytic variant: Case report and literature review.1 passage
• Proteoglycans and their functions in esophageal squamous cell carcinoma.1 passage
• Proton beam therapy of periorbital sinonasal squamous cell carcinoma: Two case reports and review of literature.1 passage
• Pseudo- or real progression? An ovarian cancer patient under nivolumab: A case report.1 passage
• Quality of life and oral potentially malignant disorders: Critical appraisal and prospects.1 passage
• Racial disparities in immune-related adverse events of immune checkpoint inhibitors and association with survival based on clinical and biochemical responses.1 passage
• Radiation-associated epithelial-myoepithelial carcinoma among five secondary malignancies: A case report and review of literature.1 passage
• Radiation-induced malignant rhabdoid tumour of the hypothalamus in an adult: A case report.1 passage
• Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck.1 passage
• Rational-emotive behavioral intervention helped patients with cancer and their caregivers to manage psychological distress and anxiety symptoms.1 passage
• Re-irradiation for high-grade gliomas: Has anything changed?1 passage
• Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer.1 passage
• Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer.1 passage
• Recent advances in microvascular autologous breast reconstruction after ablative tumor surgery.1 passage
• Recurrence-free survival as a putative surrogate for overall survival in phase III trials of curative-intent treatment of colorectal liver metastases: Systematic review.1 passage
• Recurrent aggressive mesenteric desmoid tumor successfully treated with sorafenib: A case report and literature review.1 passage
• Reduction of muscle contraction and pain in electroporation-based treatments: An overview.1 passage
• Reirradiation of recurrent breast cancer with proton beam therapy: A case report and literature review.1 passage
• Relationship and interactions of curcumin with radiation therapy.1 passage
• Relationship between Th17 immune response and cancer.1 passage
• Rescue associating liver partition and portal vein ligation for staged hepatectomy after portal embolization: Our experience and literature review.1 passage
• Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies.1 passage
• Retrospective evaluation of FOLFIRI3 alone or in combination with bevacizumab or aflibercept in metastatic colorectal cancer.1 passage
• Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase.1 passage
• Review of anticancer mechanisms of isoquercitin.1 passage
• Risk of colorectal cancer in patients with diverticular disease.1 passage
• Risk of second primary malignancies in a population-based study of adult patients with essential thrombocythemia.1 passage
• Robot-assisted laparoscopic1 passage
• Robotic technology: Optimizing the outcomes in rectal cancer?1 passage
• Role of Akt signaling in resistance to DNA-targeted therapy.1 passage
• Role of Mediterranean diet in preventing platinum based gastrointestinal toxicity in gynecolocological malignancies: A single Institution experience.1 passage
• Role of copper transporters in platinum resistance.1 passage
• Role of imaging biomarkers in mutation-driven non-small cell lung cancer.1 passage
• Role of lenalidomide in the treatment of peripheral T-cell non-Hodgkin lymphomas.1 passage
• Role of mammogram and ultrasound imaging in predicting breast cancer subtypes in screening and symptomatic patients.1 passage
• Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review.1 passage
• Role of polymorphisms in genes that encode cytokines and Helicobacter pylori virulence factors in gastric carcinogenesis.1 passage
• Role of senescence induction in cancer treatment.1 passage
• Roles of cell fusion, hybridization and polyploid cell formation in cancer metastasis.1 passage
• Roles of microRNAs in tumorigenesis and metastasis of esophageal squamous cell carcinoma.1 passage
• Salient concerns in using analgesia for cancer pain among outpatients: A cluster analysis study.1 passage
• Second-line treatments for advanced gastric cancer: Interpreting outcomes by network meta-analysis.1 passage
• Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ.1 passage
• Sentinel lymph node mapping of a breast cancer of the vulva: Case report and literature review.1 passage
• Sentinel lymph node metastasis after neoadjuvant treatment in breast cancer: Any size matters?1 passage
• Sequential treatment in disseminated well- and intermediate-differentiated pancreatic neuroendocrine tumors: Common sense or low rationale?1 passage
• Significant methodologic variations in calculating renal function changes following kidney tumor surgery: A quality reporting issue?1 passage
• Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials.1 passage
• Statins in risk-reduction and treatment of cancer.1 passage
• Stereotactic body radiation therapy for non-small cell lung cancer: A review.1 passage
• Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study.1 passage
• Stereotactic radiotherapy for prostate cancer: A review and future directions.1 passage
• Study of recombinant human interleukin-12 for treatment of complications after radiotherapy for tumor patients.1 passage
• Symptom management during and after treatment with concurrent chemoradiotherapy for oropharyngeal cancer: A review of the literature and areas for future research.1 passage
• Systemic adverse effects and toxicities associated with immunotherapy: A review.1 passage
• Target migration from re-inflation of adjacent atelectasis during lung stereotactic body radiotherapy.1 passage
• Targeted therapies in breast cancer: New challenges to fight against resistance.1 passage
• Targeting metabolism in breast cancer: How far we can go?1 passage
• Therapeutic management options for stage III non-small cell lung cancer.1 passage
• Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells.1 passage
• Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract.1 passage
• Three-dimensional bio-printing: A new frontier in oncology research.1 passage
• Thrombocytopenia with multiple splenic lesions - histiocytic sarcoma of the spleen without splenomegaly: A case report.1 passage
• Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy.1 passage
• Thymoquinone anticancer activity is enhanced when combined with royal jelly in human breast cancer.1 passage
• Tongue swelling as a manifestation of tongue metastasis from pulmonary sarcomatoid carcinoma: A case report.1 passage
• Trans-arterial chemoperfusion for the treatment of liver metastases of breast cancer and colorectal cancer: Clinical results in palliative care patients.1 passage
• Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate.1 passage
• Tumor biology in estrogen receptor-positive, human epidermal growth factor receptor type 2-negative breast cancer: Mind the menopausal status.1 passage
• Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy.1 passage
• Tumor-specific lytic path "hyperploid progression mediated death": Resolving side effects through targeting retinoblastoma or p53 mutant.1 passage
• Tunable structure priors for Bayesian rule learning for knowledge integrated biomarker discovery.1 passage
• Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors.1 passage
• Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report.1 passage
• What factors influence patient experience in orthopedic oncology office visits?1 passage
• Why natural killer cells in triple negative breast cancer?1 passage
• Wilms tumor with dilated cardiomyopathy: A case report.1 passage
• With increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs?1 passage
• Yttrium-90 microsphere selective internal radiation therapy for liver metastases following systemic chemotherapy and surgical resection for metastatic adrenocortical carcinoma.1 passage